Items where Author is "Reinmuth, N."

Article

Kropf-Sanchen, C. and Rasokat, A. and Christopoulos, P. and Wenzel, C. and Wehler, T. and Rost, M. and Kulhavy, J. and Reinmuth, N. and Schulz, C. and Scheffler, M. and Wolf, J. and Buttner, R. and Merkelbach-Bruse, S. and Thomas, M. and Stenzinger, A. and Schuetz, M. and Braeuninger, A. and Demes, M. and Hummel, H. -d. and Pfarr, N. and Gaisa, N. T. and Rawluk, J. and Berezucki, E. and Lutz, K. T. and Galda, S. and Jacobi, H. and Collienne, M. and Janning, M. and Brummer, T. and Loges, S. (2025) Treatment outcome of NSCLC patients with BRAFnon-V600E mutations: a retrospective, multicentre analysis within the national Network Genomic Medicine (nNGM) Lung Cancer in Germany. ESMO OPEN, 10 (8): 105124. ISSN , 2059-7029

Conference or Workshop Item

Schulz, Christian and Senan, S. and Shire, N. and Mak, G. and Yao, W. and Reinmuth, N. (2021) ADRIATIC: A phase III trial of durvalumab +/- tremelimumab after concurrent chemoradiation for patients with limited stage small cell lung cancer. In: Jahrestagung der Deutschen, Österreichischen und Schweizerischen Gesellschaften für Hämatologie und Medizinische Onkologie, 01.-04. Oktober 2021, Berlin, Germany.

Shah, R. and Klotz, L. and Christoph, D. C. and Ried, Michael and Wehler, T. and Reck, M. and Wesseler, C. and Bethge, A. and de Wit, M. and Hoffknecht, P. and Juergens, J. and Kopp, H.-G. and Hackanson, B. and Waller, C. F. and Reinmuth, N. and Schneider, M. A. and Krisam, J. and Christopoulos, P. and Eichhorn, M. E. and Thomas, M. (2021) Nivolumab with chemotherapy in pleural mesothelioma after surgery - NICITA. In: Jahrestagung der Deutschen, Österreichischen und Schweizerischen Gesellschaften für Hämatologie und Medizinische Onkologie, 01.-04. Oktober 2021, Berlin, Germany.

Schulz, C. and Chen, Y. and Paz-Ares, L. G. and Dvorkin, M. and Trukhin, D. and Reinmuth, N. and Garassino, M. C. and Statsenko, G. and Voitko, O. and Hochmair, M. J. and Ozguroglu, M. and Verderame, F. and Havel, L. and Losonczy, G. and Conev, N. and Hotta, K. and Ji, J. H. and Broadhurst, H. and Byrne, N. and Thiyagarajah, P. and Goldman, J. W. and Alt, J. (2020) First-line durvalumab plus platinum-etoposide in extensive-stage (ES)-SCLC (CASPIAN): Impact of brain metastases on treatment patterns and outcomes. In: Jahrestagung der Deutschen, Österreichischen und Schweizerischen Gesellschaften für Hämatologie und Medizinische Onkologie, 09.–11. Oktober 2020, Virtuell.

Shah, R. and Klotz, L. V. and Feisst, M. and Schneider, M. and Kriegsmann, M. and Ried, M. and Wesseler, C. and Christoph, D. C. C. and de Wit, M. and Juergens, J. and Kopp, H.-G. and Wehler, T. and Reck, M. and Sackmann, S. and Waller, C. and Reinmuth, N. and Bischoff, H. and Winter, H. and Eichhorn, M. and Thomas, M. (2020) NICITA: Nivolumab with chemotherapy in pleural mesothelioma after surgery. In: ESMO Virtual Congress, SEP 19-OCT 18, 2020, ELECTR NETWORK.

Stoeltzing, O. and Fan, F. and Liu, W. and Parikh, A. A. and Reinmuth, N. and Hicklin, D. J. and Ellis, L. M. (2004) Blockade of IGF-IR function reduces COX-2 expression in human pancreatic cancer cells. In: 57th Annual Cancer Symposium of the Society of Surgical Oncology, MAR 18-21, 2004, NEW YORK, NEW YORK.

Other

Alt, J. and Bischoff, H. G. and Laack, H-E and Leistner, R. D. and Panse, J. and Reinmuth, N. and Schulz, C. and Grohe, C. (2018) A Phase 3, randomized study of first-line durvalumab (D) plus /- tremelimumab (T) plus platinum-based chemotherapy (CT) vs CT alone in extensive disease small-cell lung cancer (ED-SCLC): CASPIAN. KARGER, BASEL.